CLINICAL OUTCOME OF PATIENTS TREATED WITH HEPATIC ARTERIAL INFUSION OF OXALIPLATIN AND L-FOLINIC ACID MODULATED 5-FLUOROURACIL FOR INOPERABLE COLORECTAL CANCER LIVER METASTASES, A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
van Bael, K. [1 ]
De Greve, J. [2 ]
Delvaux, G. [1 ]
Neyns, B. [3 ]
机构：
[1] Univ Ziekenhuis Brussel, Brussels, Belgium
[2] UZ Brussel, Brussels, Belgium
[3] Vrije Univ Brussel, Acad Ziekenhuis, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：221 / 221
页数：1
相关论文
共 50 条
  • [21] A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases
    Feng, Ai-Wei
    Guo, Jian-Hai
    Gao, Song
    Kou, Fu-Xin
    Liu, Shao-Xing
    Liu, Peng
    Chen, Hui
    Wang, Xiao-Dong
    Xu, Hai-Feng
    Cao, Guang
    Zhu, Xu
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Hepatic artery chronomodulated infusion of irinotecan, 5-fluorouracil and oxaliplatin against liver metastases in heavily pretreated patients with colorectal cancer.
    Bouchahda, M
    Tanaka, K
    Adam, R
    Giacchetti, S
    Brézault-Bonnet, C
    Gholam, D
    Kunslinger, F
    Castaing, D
    Jasmin, C
    Lévi, FA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 299S - 299S
  • [23] Weekly hepatic arterial infusion of 5-fluorouracil and subsequent systemic chemotherapy for liver metastases from colorectal cancer
    Hosokawa, A
    Yamada, Y
    Shimada, Y
    Muro, K
    Matsumura, Y
    Fujita, S
    Akasu, T
    Moriya, Y
    Shirao, K
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (03) : 132 - 135
  • [24] A feasibility study on hepatic arterial infusion (HAI) of oxaliplatin followed by I-folinic acid modulated continuous HAI of 5-fluorouracil as second line chemotherapy for stage IV colorectal cancer limited to the liver
    Neyns, Bart
    Van Nieuwenhove, Yves
    Fontaine, Christei
    Vermeij, Joanna
    Sermijn, Erica
    Schallier, Dennis
    De May, Johan
    Vandenbroucke, Frederik
    Delvaux, Georges
    De Greve, Jacques
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 97 - 97
  • [25] Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancer
    Gerard, B
    Bleiberg, H
    Van Daele, D
    Gil, T
    Hendlisz, A
    Di Leo, A
    Fernez, B
    Brienza, S
    [J]. ANTI-CANCER DRUGS, 1998, 9 (04) : 301 - 305
  • [26] Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer
    Wein, A
    Riedel, C
    Brückl, W
    Merkel, S
    Ott, R
    Hanke, B
    Baum, U
    Fuchs, F
    Günther, K
    Reck, T
    Papadopoulos, T
    Hahn, EG
    Hohenberger, W
    [J]. ONCOLOGY, 2003, 64 (02) : 131 - 138
  • [27] Oxaliplatin plus 5-fluorouracil: Clinical experience in patients with advanced colorectal cancer
    Bleiberg, H
    de Gramont, A
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (02) : 32 - 39
  • [28] Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
    Barone, C.
    Nuzzo, G.
    Cassano, A.
    Basso, M.
    Schinzari, G.
    Giuliante, F.
    D'Argento, E.
    Trigila, N.
    Astone, A.
    Pozzo, C.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1035 - 1039
  • [29] Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
    C Barone
    G Nuzzo
    A Cassano
    M Basso
    G Schinzari
    F Giuliante
    E D'Argento
    N Trigila
    A Astone
    C Pozzo
    [J]. British Journal of Cancer, 2007, 97 : 1035 - 1039
  • [30] A PHASE-II STUDY OF REGIONAL 5-FLUOROURACIL INFUSION WITH INTRAVENOUS FOLINIC ACID FOR COLORECTAL LIVER METASTASES
    WARREN, HW
    ANDERSON, JH
    OGORMAN, P
    KANE, E
    KERR, DJ
    COOKE, TG
    MCARDLE, CS
    [J]. BRITISH JOURNAL OF CANCER, 1994, 70 (04) : 677 - 680
12345